Satellos Bioscience Inc.
MSLE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421642
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
26
- −5 vs. Q1 2026
- Total value $59.58M
Superinvestors holding MSLE
0
- None of the superinvestors held MSLE at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MSLE insiders, newest first.
No open-market purchases or sales by MSLE insiders are on file.
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MSLE at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 938,666 | $7.23M | 0.00% | 00.0% | Unchanged |
| Siren, L.L.C. | 892,074 | $6.94M | 0.14% | 00.0% | Unchanged |
| Vivo Capital, LLC | 813,666 | $6.33M | 0.58% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 682,700 | $5.31M | 0.01% | −8,078−1.2% | Reduced |
| SPHERA FUNDS MANAGEMENT LTD. | 652,590 | $5.07M | 0.73% | +163,383+33.4% | Added |